This diagnostic/prognostic study proposes a clinically applicable large-scale bidirectional generative adversarial network for predicting the efficacy of epidermal growth factor receptor–tyrosine kinase inhibitor therapy in patients with non–small cell lung cancer. The gene discussed is EGFR; the disease is lung cancer.